Skip to main content
ENGN logo

ENGN · enGene Therapeutics Inc. · Fails to Deliver

Track ENGN — free
$1.81 -0.07 (-3.48%)
Market Cap
$125.32M
Shares
67.02M
Volume · Oct 6 61.91K Avg daily vol (3M) 808.13K

Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.

Fails to Deliver History

Settlement Date Quantity Price Value
2026-09-14 4,476 $1.80 $8,057
2026-09-11 11,478 $1.77 $20,316
2026-09-10 1,972 $1.85 $3,648
2026-09-09 5,458 $1.92 $10,479
2026-09-08 5,705 $1.82 $10,383
2026-09-04 20,792 $1.83 $38,049
2026-09-03 15,296 $1.89 $28,909
2026-09-02 41,009 $1.86 $76,277
2026-09-01 875 $1.84 $1,610
2026-08-31 5,781 $1.83 $10,579
2026-08-28 2,637 $1.91 $5,037
2026-08-25 3,338 $1.81 $6,042
2026-08-21 3,662 $1.77 $6,482
2026-08-20 20,641 $1.85 $38,186
2026-08-10 5 $1.80 $9
2026-08-05 1,866 $1.79 $3,340
2026-07-23 31 $1.85 $57
2026-07-17 1,000 $1.92 $1,920
2026-07-08 27,744 $1.92 $53,268
Showing 1–19 of 19 settlements
Key facts CIK 1980845 CUSIP 29286X101 13F (30d) 1 filings 1 filers Visit website Investor relations